By InvestAdvocate

Lagos (INVESTADVOCATE)-Drugmaker, GlaxoSmithKline Consumer Nigeria Plc said on Wednesday said its pretax profit for the year ended December 31, 2014 declined 36.2 percent to N2.752 billion from N4.314 billion recorded a year earlier.

Profit after tax (PAT) also dipped 37 percent to N1.848 billion from N2.919 billion in the corresponding period of 2013.

Revenue moved from N29.183 billion in 2013 audited period to N30.521 billion in the review period of 2014; indicating a marginal growth of 4.58 percent, the company said in a filing with the Nigerian Stock Exchange (NSE).

At the close of the session on the Nigerian bourse, share price of the drugmaker climbed up 4.99 percent, gaining N2.20. It opened the session at N44.10 and closed at N46.30.

GlaxoSmithKline on Tuesday proposed a 75 kobo per share dividend and one (1) new share for every four (4) existing shares to investors of the company.

The drugmaker said the one for four  (1 for 4) bonus issue and 75 kobo dividend is payable to shareholders whose names appear on the company’s register as at the close of business on may 13, 2015, as earlier proposed by the directors of the bank for the financial year ended December 31, 2014. Closure date is May 14 to 20, 2015.